Biafungin, or Rezafungin (CD101, ClinicalTrials.gov Identifier: NCT04368559), is a novel echinocandin targeting the 1,3--D-glucan synthase
PMID: 27012953 [4] Crockford D
A minimum of 98% is considered research grade, though 99% is strongly preferred for sensitive assays, cell culture experiments, and in vivo pre-clinical studies where compound purity directly affects reproducibility and result accuracy

Water, Hydrogenated Polydecene, Isononyl Isononanoate, Butylene Glycol, Polyglyceryl-4 Oleate, Niacinamide, Polyglyceryl-6 Oleate, Polyhydroxystearic Acid, Magnesium Sulfate, Sorbitan Sesquioleate, Hibiscus Esculentus Fruit Extract, Dipropylene Glycol, Hydroxyacetophenone, Caprylyl Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Adenosine, Disodium EDTA, Panthenol, Atelocollagen, Desamido Collagen, Hydrolyzed Collagen, Soluble Collagen, Dipotassium Glycyrrhizate, Dioscorea Japonica Root Extract, Collagen, Collagen Amino Acids, Procollagen, Leontopodium Alpinum Callus Culture Extract, Maltodextrin, Tocopherol, Nelumbo Nucifera Root Extract, Pinus Strobus Bark Extract, Copper Tripeptide-1, Dipeptide-2, Oligopeptide-1, Palmitoyl Pentapeptide-4, Tripeptide-1, Glutathione
Funding This work was supported by the Xuzhou Special fund for promoting scientific and technological innovation (no